Akzo Nobel Restates Plan to List Pharma Business

19:38 PM | January 31, 2007 | Chemical Week Editorial Staff

Akzo Nobel has restated its intention to divest a 20%-30% stake in its Organon BioSciences (OBS) pharmaceuticals business early this year through an initial public offering, quashing speculation that...